FDA Takes Further Steps to Confront Opioid Crisis Through Risk Evaluation and Mitigation Strategy Programs
FDA Takes Further Steps to Confront Opioid Crisis Through Risk Evaluation and Mitigation Strategy Programs The following is attributed to FDA Commissioner Stephen M. Hahn, M.D. News provided by Share this article Share this article SILVER SPRING, Md., Dec. 23, 2020 /PRNewswire/ -- While our efforts to combat COVID-19 remain at the forefront of our day-to-day activities, the U.S. Food and Drug Administration also continues its work on a number of important public health issues and, in particular, the opioid crisis. We remain committed to using all facets of our regulatory authority to lessen ...
Source: prnewswire.com